CASI Pharmaceuticals Inc (NASDAQ:CASI)
| 2.59 Delayed Data As of May 25 |  0.00 / 0.00%Today’s Change | 1.45 Today|||52-Week Range 6.85 | +44.69% Year-to-Date |
Latest CASI News | Press Releases
No recent news for CASI Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.59 |
| Today’s open | 2.34 |
| Day’s range | 2.34 - 2.59 |
| Volume | 260 |
| Average volume (3 months) | 31,799 |
| Market cap | $29.6M |
Data as of 3:50pm ET, 05/25/2023
Growth & Valuation
| Earnings growth (last year) | +38.40% |
| Earnings growth (this year) | +57.78% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +100.12% |
| P/E ratio | NM |
| Price/Sales | 3.63 |
| Price/Book | 0.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GSGTFGensight Biologics S... | 0.00 | 0.00% |
| NYMXNymox Pharmaceutical... | -0.04 | -8.29% |
| ---- | ||
| OCXOncoCyte Corp | -0.01 | -3.92% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 14, 2023 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $30.0M |
| Annual profit (last year) | -$36.7M |
| Net profit margin | -122.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Beijing, Beijing |
Forecasts
